STAT3 and central nervous system cancer: Since STAT3 is activated by cytokine receptor-associated tyrosine kinases or growth factor receptor intrinsic tyrosine kinases, besides antagonizing the function of relevant kinases or receptors, targeting the over-expressed ligands that inappropriately stimulate the activation of STAT3 is also a promising strategy for glioma [22].